Position in VCEL
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,609,979
-$209,174 QoQ
Shares Held
50,046
-0.9% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Madison Asset Management, LLC holds $98,918,246 across 6 Biotechnology names. VCEL ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,093,058 | $57,123,211 | |
| 2 | ARMP |
Armata Pharmaceuticals, Inc.
|
2,107,675 | $21,582,592 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,387 | $12,229,390 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,784 | $4,468,949 | |
| 5 | GMAB |
Genmab A/S
|
70,970 | $1,904,125 | |
| 6 | VCEL |
Vericel Corp
This page
|
50,046 | $1,609,979 |
All Filings in VCEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,609,979 | 50,046 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,819,153 | 50,518 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||